How severe is CVE-2025-0131?

CVE-2025-0131 has a CVSS 4.0 base score of 7.1, rated high severity.

Is CVE-2025-0131 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (3rd percentile), an estimate of the probability of exploitation in the next 30 days.

How do I fix CVE-2025-0131?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

Does CVE-2025-0131 have an EU (EUVD) identifier?

Yes. CVE-2025-0131 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-14911.

When was CVE-2025-0131 published?

CVE-2025-0131 was published on 2025-05-14 and last updated on 2026-06-17.

CVE-2025-0131

CVE-2025-0131 is a high-severity vulnerability with a CVSS 4.0 base score of 7.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-266.

Key facts

Severity: High (CVSS 4.0 base score 7.1)
EPSS exploit prediction: 0% (3rd percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-14911
Weakness: CWE-266
Published: 2025-05-14
Last modified: 2026-06-17

Description

An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM. However, execution requires that the local user also successfully exploits a race condition, which makes this vulnerability difficult to exploit.

Frequently asked questions

What is CVE-2025-0131?: An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM. However, execution requires that the local user also successfully exploits a race condition, which makes this vulnerability difficult to exploit.
How severe is CVE-2025-0131?: CVE-2025-0131 has a CVSS 4.0 base score of 7.1, rated high severity.
Is CVE-2025-0131 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (3rd percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2025-0131?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2025-0131 have an EU (EUVD) identifier?: Yes. CVE-2025-0131 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-14911.
When was CVE-2025-0131 published?: CVE-2025-0131 was published on 2025-05-14 and last updated on 2026-06-17.

References

Other CWE-266 (Incorrect Privilege Assignment) vulnerabilities

CVE-2026-23800 — Critical (CVSS 10.0): Incorrect Privilege Assignment vulnerability in Modular DS modular-connector allows Privilege Escalation.This issue…
CVE-2025-41115 — Critical (CVSS 10.0): SCIM provisioning was introduced in Grafana Enterprise and Grafana Cloud in April to improve how organizations manage…
CVE-2024-9479 — Critical (CVSS 10.0): Improper Privilege Management vulnerability in upKeeper Solutions upKeeper Instant Privilege Access allows Privilege…
CVE-2024-9478 — Critical (CVSS 10.0): Improper Privilege Management vulnerability in upKeeper Solutions upKeeper Instant Privilege Access allows Privilege…
CVE-2026-42368 — Critical (CVSS 9.9): A privilege escalation vulnerability exists in the Web Interface functionality of GeoVision LPC2011/LPC2211 1.10. A…
CVE-2026-32922 — Critical (CVSS 9.9): OpenClaw before 2026.3.11 contains a privilege escalation vulnerability in device.token.rotate that allows callers with…

Browse all CWE-266 (Incorrect Privilege Assignment) vulnerabilities →